Healthcare News

  Overview:   Speech therapy can improve the quality of life for a person with a speech disorder. It can also help people who have swallowing difficulties or have problems with reading. Speech therapy can be done in a classroom setting or at home. It can take a long time for therapy to work. However, with patience and practice can help the child in improving. During speech therapy, a speech-language pathologist works with a child to help improve communication skills. They can help people with a variety of different speech and language disorders. These disorders can be caused by a number of different factors. They can affect a child's ability to speak, listen, read, write, swallow and chew. One type of speech disorder is dysarthria. This disorder causes weakness in the muscles of speech. It may be caused by a neurological disease, a head injury, or facial paralysis. It may also be caused by an infection. Market Dynamics: Rising incidences of speech disorders and increasing

  Global Antifreeze Protein Market - Impact of the Coronavirus (COVID-19) Pandemic Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 172 million cases and 3.7 million deaths due to coronavirus (COVID-19) were reported till June 06, 2021, across the globe. Impact of COVID-19 on Demand and Supply of Antifreeze Proteins The COVID-19 pandemic and lockdown in various countries across the globe have negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has negatively impacted the entire supply chain of the pharmaceutical industry, food & beverage industry, cosmetics industry, and others mainly due to strict lockdown in several regions. However, the demand for antifreeze proteins is increasing in thi

  Developed regions such as North America, typically the U.S. have shown the most promising signs when it comes to the bioinformatics platforms market. This is due to high adoption of new and advanced technology, which is complemented by continuous research and development activates in the region. Similarly, Asia Pacific is witnessing increased interest in the field of bioinformatics platforms due to the presence of skilled personnel. Bioinformatics Platforms are collections of software applications designed to facilitate the analysis of biological information. The applications and their main functions are divided into three categories, these are Cloning Lines of Action, Gene Regulation, and Gene Function. They all can be combined into one application for better functionality. However, the applications vary depending on the needs of the user and the complexity of the job. Bioinformatics is widely used in research and development activities for either drug discovery, clinical diagnost

  Osteonecrosis is a medical term meaning "bone death." It is caused by an inflammation of the hip joint due to a reduction in blood supply. This type of bone disease can have an extensive impact on the quality of life of individuals suffering from it, making the treatment of osteonecrosis extremely important. Market Dynamics High prevalence of osteonecrosis is expected to propel growth of the osteonecrosis treatment market. For instance, according to the study, ‘Epidemiology of osteonecrosis among older adults in Sweden’, published in Springer in January 2019, the 10-year risk of osteonecrosis was 0.4% and the incidence rate was 4.7 cases/10000 person-years. Moreover, high prevalence of osteoporosis is also expected to aid in growth of the osteonecrosis treatment market. For instance, according to a study published online in February 2020 in the Journal of Clinical Endocrinology & Metabolism, for denosumab-treated women with postmenopausal osteoporosis, invasive oral

  Market Overview: Endoscope reprocessing devices are those which are made to kill the organisms in the reusable endoscopes using high disinfectants or liquid chemical solutions to expose the exterior surfaces and the interior channels. Manual cleaning, sterilization, documentation, leak testing and pre –cleaning are some of the steps performed in endoscopy reprocessing. Competitive Landscape: The major players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Steelco S.p.A., Minntech Corp PENTAX Medical, Medivators Inc., Wassenburg Medical B.V., Soluscope, ENDO-TECHNIK W.Griesat GmbH, Johnson & Johnson and Getinge AB.  Key Market Drivers: Rising prevalence of colorectal cancer and other endoscopy-related diseases are anticipated to augment the growth of the global endoscope reprocessing device market. For instance, as per the American Cancer Society, nearly 97,220 people are diagnosed with colorectal cancer and 43,030 rectal ca

  Market Overview:   Generic oncology sterile injectable are widely used for the treatment of cancers prostate, breast, colorectal, melanoma, lung, and bronchus. They have the same active ingredients as that of the branded version, with only the inactive contents of the drugs being different.   Competitive Landscape: Eli Lilly & Company, Biocon Ltd., Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and Pfizer Inc. Key Market Drivers: Growing prevalence of chronic disease such as breast, prostate, colorectal, melanoma, lung, and bronchus is driving growth of the generic oncology sterile injectable market . According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Increasing partnership and collaboration in the field of generic oncology sterile injectable is again fostering market

  Market Overview: Telerehabilitation is the application of information and communication technologies to provide rehabilitation services to patients or other healthcare professionals. It is also referred to as telecare, and it empowers individuals with a disability to take charge of their health and personal care. Using telerehabilitation services, patients can receive the same care as patients in a local health care facility. Competitive Landscape: 270 Vision Ltd., CoRehab srl, SWORD Health, S.A., MIRA Rehab Limited, re.flex, Evolv Rehabilitation Technologies S.L., Brontes Processing Ltd., Bridgeway Senior Healthcare, Rehametrics, MindMaze , DIH Medical, and Doctor Kinetic Key Market Drivers: Increasing number of partnership and collaboration among key players is a major factor augmenting growth of the market. For instance, in October 2021, WizeCare Partners with Essen Health Care to advance value-based care through personalized all-in-one telerehabilitation platform. Adv

  Viscosupplementation is a procedure in which hyaluronic acid (HA) is injected into the knee joint for the treatment of osteoarthritis (OA) of the knee. HA is a naturally occurring glycosaminoglycan and an integral component of synovial fluid and cartilage matrix present in the joints. Europe viscosupplementation market is estimated to account for  US$ 241.8 Mn  in terms of value and is expected to reach  US$ 343.6 Mn  by the end of  2027 . Europe Viscosupplementation Market: Drivers Increasing prevalence of OA is expected to propel growth of the Europe viscosupplementation market over the forecast period. For instance, according to the study, ‘Prevalence and development of hip and knee osteoarthritis according to American College of Rheumatology criteria in the CHECK cohort’, published in January 2019, in BMC Arthritis Research & Therapy, 63% of the participants in the Netherlands suffered from hip OA and 92% of participants with knee complaints were classified as having kn

  Overview: A PACS system is a database of medical images and other medical information. It is generally stored in an RIS, though radiologists may choose to view the results directly in PACS. Cloud PACS solutions, however, allow radiologists to access even more information. Moreover, many providers boast of being able to integrate PACS with RIS. However, they are unable to quantify the integration time. RIS and PACS solutions are designed to facilitate interoperability among imaging devices. This is done by creating a standardized communication interface based on DICOM standards. The RIS acts as a master system that provides image management and move control functions.   Market Dynamics: The popularity of PACS is growing all over the world and this is anticipated to propel growth of the global PACS and RIS market over the forecast period. PACS help to reduce the physical as well as time barriers linked to regular film-based retrieval, display and distribution of images. For insta

  A fibrosarcoma is an inflamed (malignant) tumor that originates from the connective fibrous tissue located at the ends of the bones of the lower arm or leg and then proceeds to spread to other surrounding tissues, causing extreme pain and complications. It's a form of cancer that typically grows slowly over an extended period of time. Fibrosarcoma may develop for several reasons, including: primary tumors at the facial prominences on one or both sides of the heart; fibrosarcoma may develop in response to an infection (such as those that occur in the stomach or esophagus); tumors may also develop on other areas of the body other than the skin. If you have any of these symptoms, you should contact your physician immediately. However, since the symptoms of fibrosarcoma are similar to those of other diseases, and because it's difficult to determine whether a disease exists, most people with fibrosarcoma are sent for check-ups each year. Market Dynamics High prevalence of canc

  The global PD-1 and PD-L1 inhibitor market was valued at  US$ 30,535.5 Mn  in 2021 and is forecast to reach a value of  US$ 77,541.1 Mn  by  2028  at a  CAGR of 14.2%  between  2022 and 2028 . The global PD-1 and PD-L1 inhibitor market is experiencing strong growth due to the rise in incidence or prevalence of cancer and growing geriatric population around the world. Moreover, increase in awareness among people about immune checkpoint inhibitors is expected to boost the growth of the market. However, high cost of cancer treatment and risk of complications associated with the treatment is expected to hamper growth of the global PD-1 and PD-L1 inhibitor market. Global PD-1 and PD-L1 Inhibitor Market: Regional Insights Based on geography, the PD-1 and PD-L1 inhibitor market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Among regions, North America is expected to gain highest share in the market during the forecast period owing

  The growing prevalence of infectious chronic diseases such as chronic kidney disease around the globe is augmenting the growth of the medical membrane market. According to the National Kidney Foundation 2018, data around 10% of the worldwide population was affected by chronic kidney disease. Moreover, growing government initiatives in research and development, development in the healthcare industry, pharmaceutical, biotechnology industry, and rising adoption of medical membranes across several industries are major factors propelling the growth of the medical membrane market. On the other hand, high capital investment for the production of membrane and surface fouling is estimated to restrict the growth of the market. The key players operating in the global medical membrane market include Nipro Corporation, Amniox, Pall Corporation, Sorin Group, Gore, Maquet Company, Merck Millipore, and others In November 2018, Merck, the vibrant science and technology company launched its new B

  A primary driver for this market is the worldwide increase in occurrence of diabetes and cancer, across all age groups. According to the World Health Organization (WHO) 2018 statistics, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Moreover according to the World Health Organization cancer factsheet 2018, Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018.  Furthermore, increasing old age population is another driver, which is anticipated to create a high growth scenario for the market. As per the World Population Prospects 2019 revision, the number of people aged 80 years or over is projected to be triple, from 143 million in 2019 to 426 million in 2050. Alternatively, factors restraining the market are complications and risks associated with the treatment including diarrhea, nausea, hair loss, vomiting, severe infections, infertility, and heart complications.   Incr